FDA tells 23andMe to halt sales of genetic test

Your Health Matters

This image provided 23andMe shows the company's logo. The U.S. Food and Drug Administration is ordering genetic test maker 23andMe Monday, Nov. 25, 2013, to halt sales of its personalized DNA test kits, saying the company has failed to show that the technology is backed by science. (AP Photo/23andMe)WASHINGTON (AP) — The Food and Drug Administration has ordered Google-backed genetic test maker 23andMe to halt sales of its personalized DNA test kits, saying the company has failed to show that the technology is supported by science.

facebookShare on Facebook
TwitterTweet
FollowFollow us
PinterestSave